Mfd. by :- Natco (Fulfilled By : Magicine Pharma)
Magicine Pharma is registered with the Government Of NCT, India, Ministry Of Health in Government of Delhi, India, registration number DL-RAJ-122372 and as a wholesale distributor, department file No. 44208.
Brand Name:- Veenat
Generic Name:- Imatinib
Dosage Form:- Tablet
Packaging:- 120 Tablet (120 / Bottle)
Indication:- Blood cancer, Bone marrow, Gastrointestinal Stromal tumor, Intestine, and skin cancer.
Storage:- Store at room temperature
Veenat (Imatinib) Tablet is used in the treatment of blood cancer (CML-chronic myeloid leukemia and acute lymphocytic leukemia) and gastrointestinal stromal tumor. This medicine should be taken with food. Do not take this medicine in the wrong way as it may lead to some severe side effects. Take this medicine as prescribed by your medical advisor. It is advisable not to change or stop the dose without taking suggestions from the doctor. If you experience any symptoms while receiving this medicine, inform your doctor immediately. Close monitoring of blood cells and liver function is required while receiving this medicine.To know Imatinib price contact Magicine Pharma.
Veenat is a protein tyrosine kinase inhibitor that inhibits the BCR-ABL tyrosine kinase, the consecutive abnormal tyrosine inhibitor created by Philadelphia chromosome abnormality in CML. After the oral administration, the effect of this medicine can be observed in 2-4 hours.
This medicine may cause some serious and unwanted side effects. It requires immediate medical attention otherwise it can also lead to higher risk. Discuss the risks and benefits of this medication with a medical advisor before starting the treatment.
Loss of appetite
Shortness of breath
Change in vision
Swelling around the eyes
Lack of sleep
Numbness of the hand or feet
Note- contact your doctor if any side effects occur.
Take this medicine as prescribed by your doctor. Do not crush or chew. Do not take this medicine on an empty stomach.
It is advisable not to miss a dose. If you miss a scheduled dose of Veenat 400mg Tablet, contact your doctor immediately.
In case of an overdose, the doctor will provide emergency medical treatment.
This medicine is used to treat types of cancers (blood cancer, stomach, intestine, bone marrow, and skin). This medicine helps to prevent the growth of cancerous cells in the body. Veenat is used for the treatment of tumors that start in the wall lining the stomach and intestine. This medicine belongs to the class of medicines known as tyrosine kinase inhibitors. Do not take this medicine on an empty stomach. Take the medicine at the same time every day to get the most benefit from it. Try not to miss your regular dosing schedule. Take this medicine as prescribed by your medical advisor. Do not crush or chew the capsule. The dose is decided by a medical advisor according to response to the treatment and your previous medical condition.
Before starting treatment with Veenat, please inform your doctor about your previous medical history. If you experience any symptoms while receiving this medication, do not ignore those symptoms because it may lead to higher risk.
Use effective methods of contraception to prevent pregnancy while taking this medicine.
Children and adolescents
Veenat capsule is advisable for use in children and adolescents who have CML(Chronic myeloid leukemia).
Veenat shouldn’t be used by pregnant women. Imatinib may cause harm to the baby. It is recommended that this medicine should be avoided during pregnancy.
This medicine is not recommended in breastfeeding unless it is necessary. Please consult your medical advisor before starting treatment with this medication.
People who are suffering from gastrointestinal disorders shouldn’t use this medicine without consulting with their doctor.
This medicine may increase the risk of congestive heart failure.
Veenat capsules should be used with caution in patients having a low level of thyroid hormones.
Avoid activities that may increase the risk of bleeding.
This medicine may cause blurry vision.
In children, there is a risk of growth retardation.
Avoid contact with people who have infections.
Do not crush or chew the capsule.
Do not drive or operate heavy machinery.
Not safe for pregnant women.
Do not breastfeed while receiving this medication.
Ans. Veenat 400mg Tablet is used in the treatment of blood cancer (chronic myeloid leukemia and acute lymphocytic leukemia) and gastrointestinal stromal tumor.
Ans. Veenat 400mg Tablet stop the growth of cancer cells. This medicine inhibits the proliferation and induces apoptosis (planned cell death) in BCR-ABL positive cells (cancer cells).
Ans. It is available in the strength of 100mg and 400mg.
Ans. Some common side effects are:- vomiting, diarrhea, rash, constipation, irregular heartbeat, fatigue, blurred vision, insomnia, bleeding, sore throat, etc.
Ans. Follow the doctor’s instructions about any restrictions on food and other activities.
Ans. If you miss a scheduled dose of this medicine, contact your doctor immediately.
Ans. This medicine may decrease your ability to drive or affect your vision. Do not drive if any symptoms occur.
Ans. This medicine is not recommended for pregnant women.
Ans. Maintain good nutrition and keep yourself hydrated.
Ans. This medicine is not recommended in breastfeeding unless it is necessary.
Ans. The use of a Veenat 400mg Tablet is not recommended in patients with severe liver disease.
Ans. It is not known whether it is safe or not. Please consult your doctor before consuming alcohol.
Ans. Store this medicine at room temperature.
Ans. This medicine can affect your kidney function. Please consult your medical advisor before consuming this drug.
Interactions may change how your medication works and increase the risk for side effects. Don’t forget to disclose your previous medical history with the doctor.
Heart and blood vessel disorder
Bone marrow suppression
Interaction with alcohol is unknown. Please consult your doctor before consuming alcohol.
Veenat capsule is not recommended for use in patients with known allergy to Imatinib.
This medicine is contracted in patients known to be hypersensitive.